Himanshu Gadgil, Ph.DCEO at Enzene Biosciences Ltd.Speaker
Profile
Dr. Himanshu Gadgil brings with him 24 years of experience in the pharmaceutical industry. He is the Chief Executive Officer at Enzene Biosciences Ltd. presiding over all business functions of the company. Under his leadership, Enzene has grown from a start-up biotech to a multi-vertical, multi-site product development and manufacturing service-based biopharmaceutical company.
Previously, as Sr. Vice President at Intas Pharmaceutical Ltd., he revitalized the commercial product pipeline, launching several biosimilar products globally. During his stint in the US, he led different facets of process and product development at Amgen, spearheading IND, BLA and Market authorizations of various blockbuster biotech products. At the inception of his career, he joined Waters Corporation where he pioneered development of QBD enabling multi-attribute methodologies for biopharmaceutical characterization.
Dr. Gadgil holds a PhD in Biochemistry from University of Tennessee and is a passionate scientific leader and innovator with over 50 publications and patents.
Agenda Sessions
Advances and Implementation of Process Intensification an Overview Followed by Panel Discussion with Industry Experts
, 1:00pmView SessionSelection and Implementation of a Cost Effective High Productive Continuous Process for Flexible and Agile Manufacturing
, 8:15amView Session